These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18848768)

  • 1. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats.
    Guo Z; Wang S; Jiao Q; Xu M; Xu Z
    Biomed Pharmacother; 2009 Aug; 63(7):537-42. PubMed ID: 18848768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB
    J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of soluble tumor necrosis factor receptor-II on endotoxin-mediated hemodynamic instability.
    Anderson JA; Knott AW; Wilson MA; Garrison RN; Sims DE; Edwards MJ
    J Surg Res; 1995 Jan; 58(1):53-7. PubMed ID: 7830406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
    Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.
    Fisher CJ; Agosti JM; Opal SM; Lowry SF; Balk RA; Sadoff JC; Abraham E; Schein RM; Benjamin E
    N Engl J Med; 1996 Jun; 334(26):1697-702. PubMed ID: 8637514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.
    Bemelmans MH; Gouma DJ; Buurman WA
    J Immunol; 1993 Nov; 151(10):5554-62. PubMed ID: 8228246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFR-Fc fusion protein expressed by in vivo electroporation improves survival rates and myocardial injury in coxsackievirus induced murine myocarditis.
    Kim JM; Lim BK; Ho SH; Yun SH; Shin JO; Park EM; Kim DK; Kim S; Jeon ES
    Biochem Biophys Res Commun; 2006 Jun; 344(3):765-71. PubMed ID: 16631119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein.
    Kim JM; Ho SH; Hahn W; Jeong JG; Park EJ; Lee HJ; Yu SS; Lee CS; Lee YW; Kim S
    Gene Ther; 2003 Aug; 10(15):1216-24. PubMed ID: 12858186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept decreases tumor necrosis factor-alpha activity in chronic wound fluid.
    Cowin AJ; Hatzirodos N; Rigden J; Fitridge R; Belford DA
    Wound Repair Regen; 2006; 14(4):421-6. PubMed ID: 16939569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low-protein diet and protein supplementation on the expressions of TNF-alpha, TNFR-I, and TNFR-II in organs and muscle of LPS-injected rats.
    Raina N; Jeejeebhoy KN
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E481-7. PubMed ID: 14625205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS-induced suppression of gastric motility relieved by TNFR:Fc construct in dorsal vagal complex.
    Hermann GE; Tovar CA; Rogers RC
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G634-9. PubMed ID: 12181177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS induces the TNF-alpha-mediated downregulation of rat liver aquaporin-8: role in sepsis-associated cholestasis.
    Lehmann GL; Carreras FI; Soria LR; Gradilone SA; Marinelli RA
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G567-75. PubMed ID: 18174273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin tolerance in rats: expression of TNF-alpha, IL-6, IL-10, VCAM-1 AND HSP 70 in lung and liver during endotoxin shock.
    Flohé S; Dominguez Fernández E; Ackermann M; Hirsch T; Börgermann J; Schade FU
    Cytokine; 1999 Oct; 11(10):796-804. PubMed ID: 10525319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression.
    Glabinski AR; Bielecki B; Kawczak JA; Tuohy VK; Selmaj K; Ransohoff RM
    Autoimmunity; 2004; 37(6-7):465-71. PubMed ID: 15621573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vipera aspis venom reduces lethality and down-regulates tumor necrosis factor-alpha in a rat model of LPS-induced sepsis.
    Frolkis I; Klein Y; Locker C; Adi N; Dahan E; Uretzsky G; Shapira I; Sorkine P
    Cytokine; 2010 Mar; 49(3):319-24. PubMed ID: 20034812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxpentifylline inhibits tumor necrosis factor-alpha mRNA transcription and protects against arthritis in mercuric chloride-treated brown Norway rats.
    Kiely PD; Gillespie KM; Oliveira DB
    Eur J Immunol; 1995 Oct; 25(10):2899-906. PubMed ID: 7589090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of some drugs on the levels of selected cytokines in experimental septic shock].
    Ladny JR; Dzienis H; Dadan J; Polaków J; Venskutonis D; Puchalski Z
    Wiad Lek; 1997; 50 Suppl 1 Pt 2():247-51. PubMed ID: 9424882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity.
    Steinshamn S; Bemelmans MH; Buurman WA; Waage A
    Cytokine; 1995 Jan; 7(1):50-6. PubMed ID: 7749066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.
    Moreland LW; Baumgartner SW; Schiff MH; Tindall EA; Fleischmann RM; Weaver AL; Ettlinger RE; Cohen S; Koopman WJ; Mohler K; Widmer MB; Blosch CM
    N Engl J Med; 1997 Jul; 337(3):141-7. PubMed ID: 9219699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.
    Mease PJ; Wei N; Fudman EJ; Kivitz AJ; Schechtman J; Trapp RG; Hobbs KF; Greenwald M; Hou A; Bookbinder SA; Graham GE; Wiesenhutter CW; Willis L; Ruderman EM; Forstot JZ; Maricic MJ; Dao KH; Pritchard CH; Fiske DN; Burch FX; Prupas HM; Anklesaria P; Heald AE
    J Rheumatol; 2010 Apr; 37(4):692-703. PubMed ID: 20032102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.